RRS® HA Long Lasting is an advanced HA-based skin booster formulated to provide prolonged hydration, skin revitalisation, and visible improvement in early wrinkles and skin laxity. Combining cross-linked hyaluronic acid with an amino acid protective complex, the treatment supports dermal regeneration while improving skin elasticity and radiance.
The product is widely used in professional aesthetic practice for patients experiencing dehydration, photodamage, loss of firmness, or tired-looking skin. Its hybrid formulation bridges the gap between traditional mesotherapy and soft tissue rejuvenation, offering a refreshed and smoother skin appearance with long-lasting hydration support.
Pricing is available to registered aesthetic professionals only.
Sign in to view pricesRRS® HA Long Lasting is a sterile, resorbable dermal implant designed for skin revitalisation, long-lasting hydration, and improvement of early signs of skin ageing. Developed by Skin Tech Pharma Group, the product combines BDDE cross-linked hyaluronic acid with a protective amino acid buffer intended to support hydration, antioxidant protection, and dermal regeneration.
RRS® HA Long Lasting is positioned within the category of hybrid skin boosters and biorevitalising injectables. It is commonly used to improve skin elasticity, superficial to moderate wrinkles, dermal atrophy, and photoaged skin. The formulation contains 21 mg/3 ml cross-linked hyaluronic acid together with 15 amino acids that help stabilise the HA while supporting tissue quality and hydration.
The product is frequently selected for patients presenting with dull, dehydrated, lax, or prematurely aged skin, particularly in facial areas such as the cheeks, jawline, nasolabial folds, and marionette lines. Results may remain visible for approximately 9–12 months depending on patient-specific factors and treatment protocol.
RRS® HA Long Lasting is often compared with injectable skin boosters and biorevitalisers such as Profhilo and Jalupro Super Hydro due to its focus on hydration, skin quality improvement, and collagen-supportive activity.
Like Profhilo®, RRS® HA Long Lasting uses hyaluronic acid to improve hydration and skin elasticity. However, RRS® HA Long Lasting incorporates an amino acid protective buffer and cross-linked HA structure intended to prolong hydration effects and support antioxidant activity.
Compared with Jalupro Super Hydro, RRS® HA Long Lasting also combines HA with amino acids, but it is generally positioned more toward long-lasting hydration and dermal support rather than intensive collagen biostimulation alone. The product is additionally described by some distributors as a hybrid between a skin booster and a soft dermal filler due to its cross-linked HA composition.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Manufacturer and distributor information indicates use for:
Primary indications include:
According to publicly available manufacturer and distributor guidance:
Some practitioners apply a “7-point technique”; however, this is not clearly established within the official manufacturer IFU guidance and may vary according to practitioner preference.
Active ingredients include:
Lidocaine concentration: not provided by manufacturer
Shelf life: not provided by manufacturer
Contraindications and precautions may include:
As with all injectable aesthetic procedures, temporary redness, swelling, bruising, tenderness, or irritation may occur following administration.
RRS® HA Long Lasting is described as a Class III sterile medical device manufactured in conformity with European Directive 93/42/EEC.
CE marking status is referenced within public manufacturer documentation. Users should verify the latest regulatory classification directly from the product packaging or official IFU before purchase or administration.
RRS® HA Long Lasting is commonly described as a hybrid product positioned between a skin booster, biorevitaliser, and soft dermal implant. While it contains cross-linked hyaluronic acid similar to dermal fillers, its primary objective is skin hydration, revitalisation, and improvement of skin quality rather than major volumisation. Some distributors refer to it as a “hybrid filler” because of its prolonged hydration effect and structural support properties.
The formulation contains 21 mg of BDDE cross-linked hyaluronic acid in a 3 ml syringe combined with a protective amino acid buffer containing 15 amino acids. The amino acids are intended to support hydration, antioxidant activity, and tissue regeneration while helping stabilise the hyaluronic acid.
Publicly available product information suggests that results may remain visible for approximately 9–12 months. Longevity can vary according to patient age, skin condition, lifestyle, metabolic activity, and treatment technique. Some practitioners may recommend maintenance or booster sessions to prolong clinical outcomes.
The product is primarily indicated for facial rejuvenation and skin quality improvement. Commonly treated areas include the cheeks, jawline, chin, nasolabial folds, marionette lines, hands, and décolletage. It is frequently selected for dehydrated, photoaged, or lax skin showing early ageing changes.
Available manufacturer-related guidance indicates administration into the deep dermis using a fine needle, commonly a 30G needle. Publicly accessible documentation does not consistently specify volume per injection point or a mandatory treatment protocol, therefore practitioners should consult the official IFU before use.
Let’s talk on WhatsApp